Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).

Details

Request a copyRequest a copy
Serval ID
serval:BIB_14C6A3C59476
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
Journal
The British journal of dermatology
Author(s)
Tzoumpa S., Ingen-Housz-Oro S., de Masson A., Pham-Ledard A., El Aarbaoui T., Dereure O., Quereux G., Faiz S., de Vicq de Cumptich M., Ram-Wolff C., Janela-Lapert R., Guenova E., Lheure C., Le Corre Y., Adamski H., Blanchard M., Bonnet N., Amatore F., Grange F., Troin L., Bagot M., Beylot-Barry M.
ISSN
1365-2133 (Electronic)
ISSN-L
0007-0963
Publication state
Published
Issued date
20/06/2024
Peer-reviewed
Oui
Volume
191
Number
1
Pages
143-144
Language
english
Notes
Publication types: Letter ; Multicenter Study ; Journal Article
Publication Status: ppublish
Keywords
Humans, Sezary Syndrome/drug therapy, Retrospective Studies, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Male, Female, Aged, Skin Neoplasms/drug therapy, Skin Neoplasms/pathology, Middle Aged, Disease Progression, Withholding Treatment, Aged, 80 and over, Adult
OAI-PMH
oai:serval.unil.ch:BIB_14C6A3C59476
DOI
10.1093/bjd/ljae153
Pubmed
38660811
Web of science
001221802600001
Create date
03/05/2024 14:12
Last modification date
16/07/2024 6:08
Usage data